Arbe Robotics Ltd. — FY2022 Form 20-F Summary
Reporting period: Fiscal year ended December 31, 2022. The filing is an annual report, not a standalone Q4 report; it does not provide clear Q4-only financial results. Figures below are in U.S. dollars unless stated otherwise. Financial statements are prepared under U.S. GAAP.
Business context
Arbe is an Israeli fabless semiconductor company developing 4D imaging-radar chipsets and perception software for ADAS, autonomous vehicles, and other applications. It sells mainly to Tier 1 suppliers and OEMs, while relying on third parties for manufacturing. Most revenue to date came from products for testing and evaluation rather than scaled commercial deliveries.
Financial performance and liquidity
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $3.517 million | $2.249 million |
| Cost of revenue | $1.283 million | $1.440 million |
| Gross profit / margin | $2.234 million / 63.5% | $0.809 million / 36.0% |
| Research and development | $36.731 million | $28.564 million |
| Sales and marketing | $4.621 million | $1.814 million |
| General and administrative | $8.613 million | $3.709 million |
| Operating loss | $(47.731) million | $(33.278) million |
| Net loss | $(40.494) million | $(58.092) million |
| Net cash used in operating activities | $(40.362) million | $(26.416) million |
- Revenue increased approximately 56%, primarily from chipset sales. Gross margin rose as revenue grew and product mix and unit costs improved.
- Operating expenses increased approximately 47%, led by higher R&D, personnel and share-based compensation, and public-company costs. The operating loss widened despite higher revenue.
- Net loss narrowed mainly because financial results included a $7.237 million net financial gain in 2022, versus $24.814 million of net financial expense in 2021. These amounts were materially affected by non-cash fair-value remeasurement of warrants and, in 2021, a convertible loan; they do not reflect improvement in operating profitability.
- At year-end, cash and cash equivalents were $54.171 million; current assets were $58.756 million, current liabilities $10.429 million, and working capital $48.327 million. Shareholders’ equity was $48.753 million. The company reported no debt at December 31, 2022; warrant liabilities were $1.631 million.
- Cash and cash equivalents fell from $100.811 million at year-end 2021. Financing cash outflow in 2022 was $4.941 million, principally repayment of the short-term loan. The Scintilla loan was repaid June 30, 2022.
- Revenue remains concentrated: three customers accounted for 33.4%, 19.4% and 18.9% of 2022 revenue. China represented 42.0% and Sweden 36.3% of revenue.
Material developments, outlook and risks
- Management said it expected expenses to decrease in 2023 as production build-up stabilized and the company streamlined operations, while continuing product development and commercialization spending. It anticipated existing cash and revenue would fund operations until cash-flow positive, but cautioned that additional losses and funding needs could arise. No specific revenue, earnings or cash-flow guidance is provided.
- The filing estimated commercial-quantity availability in late 2023, subject to product readiness and manufacturing capacity. HiRain issued a preliminary order for 340,000 chipsets for 2023–2024; it was not included in backlog. The filing states that orders and customer evaluations do not assure production contracts or revenue.
- Arbe reported work with six Tier 1 suppliers and numerous evaluation programs. These relationships and customer selections are not equivalent to binding commercial-volume orders. A planned 400,000-radar AutoX integration was conditional on product and support meeting AutoX requirements.
- GlobalFoundries is the company’s manufacturing supplier and a significant supply-chain dependency. Alternative chip sourcing could require redesign and take up to two years. The company also flagged automotive qualification timelines, customer cancellations or delays, pricing pressure, component costs and the need to scale production as significant risks.
- Other material risks include continued losses, uncertain market adoption, customer concentration, competition, geopolitical and macroeconomic disruption, semiconductor shortages, cybersecurity and product-liability exposure, and Israeli political or security conditions. Management reported no material COVID-19 impact in 2022.
- The company had received approximately $3.729 million in IIA grants through year-end. Royalties are generally 4% of relevant product sales, subject to the terms and repayment cap described in the financial-statement notes. The filing reports no current legal proceedings.
- Management concluded disclosure controls were effective at December 31, 2022. The auditor issued an unqualified opinion on the financial statements but did not audit or opine on internal control over financial reporting. A portion of the company’s cash had been held at Silicon Valley Bank; the filing says it was transferred to other institutions after the bank’s closure.
Investor verification priorities
- Confirm conversion of evaluation activity and preliminary orders into binding, production-volume contracts, and verify shipment timing, customer conditions and backlog.
- Assess cash burn and runway against the $54.2 million year-end cash balance, the expected 2023 spending reductions and the path to cash-flow positivity.
- Reconcile reported per-share and weighted-average-share figures: the filing’s MD&A table and audited notes contain inconsistent weighted-average share counts for 2022.
- Review customer concentration, the non-binding or conditional status of key arrangements, and the effects of any delays or cancellations.
- Evaluate manufacturing capacity, supplier concentration, automotive-grade qualification, unit economics and the expected margins at commercial scale.
- Separate operating performance from non-cash warrant and convertible-instrument revaluations when assessing net loss and period-to-period changes.